$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
06:50pm, Sunday, 08'th Jun 2025
Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (HIMS 6.96%) may finally be succeeding in cracking the code.
Is Hims & Hers Health a Smart Buy Right Now?
06:52pm, Saturday, 07'th Jun 2025
When it comes to stocks that continue to beat the market, my guess is that your mind goes straight to companies leading the charge in artificial intelligence (AI). Sure, stocks such as Palantir Techno
This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space
04:15am, Saturday, 07'th Jun 2025
Telehealth has gone through a major boom-and-bust cycle. One promising stock emerging from the bust is Hims & Hers (HIMS 6.96%).
HIMS' Buyouts Fuel International Expansion & Digital Health Innovation
01:21pm, Thursday, 05'th Jun 2025
Hims & Hers accelerates European growth with new ZAVA acquisition, adding localized care and lab testing innovation.
Hims & Hers Stock: Buy the Dip or Wait It Out?
08:29am, Thursday, 05'th Jun 2025
One of the most exciting growth stories in the market is that of Hims & Hers Health Inc. NYSE: HIMS. This company has combined the growth and efficiency aspects of the technology sector with the safe
Hims & Hers Goes on a Buying Spree
06:16am, Thursday, 05'th Jun 2025
Hims & Hers (HIMS -1.76%) is using some of its recent $1 billion capital raise to buy ZAVA, a European healthcare company. In this video, Travis Hoium explains why this will keep the company's revenue
Hims & Hers ZAVA Acquisition Deal Expands Its Market Opportunity By $52 Billion: Analyst
03:08pm, Wednesday, 04'th Jun 2025
Hims & Hers Health, Inc. HIMS on Tuesday agreed to acquire ZAVA, a European digital health platform. The deal terms were not disclosed.
HIMS Stock Falls Despite Latest Deal to Expand International Footprint
01:35pm, Wednesday, 04'th Jun 2025
Hims & Hers is set to acquire ZAVA to launch in Germany, France and Ireland, deepening its personalized digital health push.
Why Is Hims & Hers Health (HIMS) Up 10.6% Since Last Earnings Report?
12:36pm, Wednesday, 04'th Jun 2025
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock?
2 Incredible Growth Stocks to Buy Hand Over Fist
07:15am, Wednesday, 04'th Jun 2025
The most explosive returns in 2025 aren't coming from household names or blue chip stalwarts. Instead, they're emerging from companies at the bleeding edge of technological disruption, where visionary
Hims & Hers stock price jumps: Telehealth company acquires Zava, picking up over a million Europe customers
04:01pm, Tuesday, 03'rd Jun 2025
American telehealth company Hims & Hers Health announced on Tuesday that it will be acquiring Zava, a leading European digital health company in an all cash acquisition set to close in the second half
Which Telehealth Stock Should You Be Targeting?
03:22pm, Tuesday, 03'rd Jun 2025
Hims & Hers Health Inc (NYSE:HIMS) stock made waves in premarket trading, after the telehealth firebrand announced the pending acquisition of ZAVA, a European digital health platform.
S&P 500 (NYSEARCA: SPY) Live: Broader Markets Stall on Trade Deal Worries
01:30pm, Tuesday, 03'rd Jun 2025
Live Updates Live Coverage Updates appear automatically as they are published. Wall Street Turns Bullish on UEC 12:06 pm by Gerelyn Terzo BMO Capital Markets has added nuclear power stock Uranium Ener
Live Nasdaq Composite: Markets Lack Conviction Amid Trade Deal Uncertainty
01:30pm, Tuesday, 03'rd Jun 2025
Live Updates Live Coverage Updates appear automatically as they are published. Nuclear Focus 12:00 pm by Gerelyn Terzo Wall Street firm BMO Capital Markets has initiated coverage of nuclear stock Uran
Top Stock Movers Now: Dollar General, Hims & Hers, Bumble, and More
12:10pm, Tuesday, 03'rd Jun 2025
U.S. equities rose at midday as the markets continued to wait for more information about possible U.S. trade deals. The Dow Jones Industrial Average, S&P 500, and Nasdaq were slightly higher.
Sign In
Buy HIMS